Oncology Data Advisor

The Latest Data on Zanidatamab for HER2-Positive Biliary Tract Cancer: Shubham Pant, MD

Informações:

Synopsis

The Latest Data on Zanidatamab for HER2-Positive Biliary Tract Cancer: Shubham Pant, MD by i3 Health